Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability (Q33912628)

30 July 2017

title

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: a biomarker of blood-cerebrospinal fluid barrier permeability (English)

1 reference

blood-cerebrospinal fluid barrier

30 July 2017

0 references

0 references

1 reference

2

Henrik Zetterberg

1 reference

30 July 2017

3

Kaj Blennow

1 reference

30 July 2017

5

Inge Grundke-Iqbal

1 reference

30 July 2017

4

Tormod Fladby

1 reference

30 July 2017

Sonia Chalbot

1

1 reference

30 July 2017

Khalid Iqbal

series ordinal

6

1 reference

30 July 2017

language of work or name

English

0 references

publication date

12 May 2010

1 reference

30 July 2017

1 reference

30 July 2017

volume

478

1 reference

30 July 2017

issue

3

1 reference

30 July 2017

page(s)

179-183

1 reference

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity is increased in Alzheimer disease

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Blood-neural barrier: its diversity and coordinated cell-to-cell communication

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Secretory PLA2-IIA: a new inflammatory factor for Alzheimer's disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Secreted phospholipase A2 activity in experimental autoimmune encephalomyelitis and multiple sclerosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Secretory phospholipases A2 in inflammatory and allergic diseases: not just enzymes.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Cytosolic phospholipase A2 alpha-deficient mice are resistant to experimental autoimmune encephalomyelitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Enhanced prospects for drug delivery and brain targeting by the choroid plexus-CSF route

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Phospholipase A2 inhibitors as potential anti-inflammatory agents

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Phospholipase A2 in the central nervous system: implications for neurodegenerative diseases

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Inflammatory mediators and modulation of blood-brain barrier permeability

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Blood-cerebrospinal fluid barrier dysfunction for high molecular weight proteins in Alzheimer disease and major depression: indication for disease subsets.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Measurement of IgG and albumin content of cerebrospinal fluid, and its interpretation

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Multiple sclerosis: gadolinium enhancement in MR imaging.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Statistical methods for assessing agreement between two methods of clinical measurement

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Heterogeneity of blood-brain barrier changes in multiple sclerosis: an MRI study with gadolinium-DTPA enhancement.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

A new general regression-based approach for method comparison studies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Molecular markers of brain damage: current state and future perspectives

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Soluble Fas (Apo-1) levels in cerebrospinal fluid of multiple sclerosis patients.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Protein analysis in cerebrospinal fluid. II. Reference values derived from healthy individuals 18-88 years of age.

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Breakdown of the blood-brain barrier precedes symptoms and other MRI signs of new lesions in multiple sclerosis. Pathogenetic and clinical implications

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2885518

Extracellular phospholipase A2 inhibitors suppress central nervous system inflammation

29 October 2018

1 reference

12 December 2020

CSF and serum levels of soluble fractalkine (CX3CL1) in inflammatory diseases of the nervous system

1 reference

12 December 2020

Incidence of CSF abnormalities in siblings of multiple sclerosis patients and unrelated controls

1 reference

12 December 2020

Alterations in the activity of phospholipases A2 in postmortem white matter from patients with multiple sclerosis

1 reference

12 December 2020

beta-Amyloid and interleukin-1beta induce persistent NF-kappaB activation in rat primary glial cells

1 reference

12 December 2020

CSF characteristics in early-onset multiple sclerosis

1 reference

12 December 2020

Is NSF only the tip of the "gadolinium toxicity" iceberg?

1 reference

12 December 2020

Immunology of multiple sclerosis

1 reference

12 December 2020

10.1016/J.NEULET.2010.05.012

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference